Insmed (INSM) Non Operating Income (2013 - 2014)

Insmed's (INSM) quarterly Non Operating Income came in at -$19000.0 in Q1 2014, down 1050.0% year-on-year from $2000.0 in Q1 2013, and down 1050.0% quarter-over-quarter from $2000.0 in Q1 2013.

Insmed (INSM) Non Operating Income (2013 - 2014) Analysis & Trends

Insmed's Non Operating Income history runs 2 years deep, the most recent figure standing at -$19000.0 for Q1 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -9.22 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 5.75 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -8.59 Mn
10 Insmed 23.26 Bn 22.03 Bn 258.54 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2014 -19,000.00
Mar 31, 2013 2,000.00